BMJ Open Diabetes Research & Care - BMJ Open Diabetes Research & Care is published by BMJ in partnership with the American Diabetes Association (ADA). Impact factor recently released: 5.067 #diabetes https://drc.bmj.com/
![BMJ Open Diabetes Research & Care Referencing Guide · BMJ Open Diabetes Research & Care citation (updated Jan 14 2023) · Citationsy BMJ Open Diabetes Research & Care Referencing Guide · BMJ Open Diabetes Research & Care citation (updated Jan 14 2023) · Citationsy](https://citationsy.com/styles/img/bmj-open-diabetes-research-and-care.png?width=1360&height=700&style=BMJ%20Open%20Diabetes%20Research%20&%20Care)
BMJ Open Diabetes Research & Care Referencing Guide · BMJ Open Diabetes Research & Care citation (updated Jan 14 2023) · Citationsy
![Lehrstuhl für Epidemiologie und Helmholtz Zentrum München veröffentlichen Artikel in „BMJ Open Diabetes Research & Care“ - Fakultät für Sport- und Gesundheitswissenschaften Lehrstuhl für Epidemiologie und Helmholtz Zentrum München veröffentlichen Artikel in „BMJ Open Diabetes Research & Care“ - Fakultät für Sport- und Gesundheitswissenschaften](https://www.sg.tum.de/fileadmin/tuspfsp/www/pics/bmjdrc-default-issue-cover_0.png)
Lehrstuhl für Epidemiologie und Helmholtz Zentrum München veröffentlichen Artikel in „BMJ Open Diabetes Research & Care“ - Fakultät für Sport- und Gesundheitswissenschaften
![PDF) In-hospital hyperglycemia but not diabetes mellitus alone is associated with increased in-hospital mortality in community-acquired pneumonia (CAP): a systematic review and meta-analysis of observational studies prior to COVID-19 PDF) In-hospital hyperglycemia but not diabetes mellitus alone is associated with increased in-hospital mortality in community-acquired pneumonia (CAP): a systematic review and meta-analysis of observational studies prior to COVID-19](https://i1.rgstatic.net/publication/361789641_In-hospital_hyperglycemia_but_not_diabetes_mellitus_alone_is_associated_with_increased_in-hospital_mortality_in_community-acquired_pneumonia_CAP_a_systematic_review_and_meta-analysis_of_observational_/links/62c544bc721b9c41cc32a179/largepreview.png)
PDF) In-hospital hyperglycemia but not diabetes mellitus alone is associated with increased in-hospital mortality in community-acquired pneumonia (CAP): a systematic review and meta-analysis of observational studies prior to COVID-19
Recruitment, retention, and training of people with type 2 diabetes as diabetes prevention mentors (DPM) to support a healthcare
Evaluation of a type 2 diabetes prevention program using a commercial weight management provider for non-diabetic hyperglycemic
![BMJ Open Diabetes Research & Care Referencing Guide · BMJ Open Diabetes Research & Care citation (updated Jan 14 2023) · Citationsy BMJ Open Diabetes Research & Care Referencing Guide · BMJ Open Diabetes Research & Care citation (updated Jan 14 2023) · Citationsy](https://citationsy.com/styles/img/bmj-open-diabetes-research-and-care.png?width=1200&height=900&style=BMJ%20Open%20Diabetes%20Research%20&%20Care)
BMJ Open Diabetes Research & Care Referencing Guide · BMJ Open Diabetes Research & Care citation (updated Jan 14 2023) · Citationsy
Plasma glucose and insulin response to two oral nutrition supplements in adults with type 2 diabetes mellitus
Are depressive symptoms associated with quality of care in diabetes? Findings from a nationwide population-based study
![PDF) Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4) PDF) Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4)](https://i1.rgstatic.net/publication/337849715_Improved_well-being_and_decreased_disease_burden_after_1-year_use_of_flash_glucose_monitoring_FLARE-NL4/links/5deefbab299bf10bc34eb5ab/largepreview.png)
PDF) Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4)
![PDF) Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, PDF) Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized,](https://i1.rgstatic.net/publication/365420170_Add-on_imeglimin_versus_metformin_dose_escalation_regarding_glycemic_control_in_patients_with_type_2_diabetes_treated_with_a_dipeptidyl_peptidase-4_inhibitor_plus_low-dose_metformin_study_protocol_for/links/63754f3454eb5f547cda2042/largepreview.png)